0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Meperidine (Demerol) Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-38Y8476
Home | Market Reports | Health| Pharmacy
Global Meperidine Demerol Market Insights Forecast to 2028
BUY CHAPTERS

Global Meperidine (Demerol) Market Research Report 2025

Code: QYRE-Auto-38Y8476
Report
January 2025
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Meperidine (Demerol) Market

The global market for Meperidine (Demerol) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Meperidine, also known as Demerol, is a synthetic narcotic analgesic drug and a type of narcotic drug. Its main action is to reduce pain by affecting the central nervous system. Meperidine is typically used for moderate to severe pain management, such as pain after surgery or severe chronic pain.
North American market for Meperidine (Demerol) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Meperidine (Demerol) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Meperidine (Demerol) include Pfizer Inc, Purdue Pharma, Boehringer Ingelheim, Janssen Pharmaceuticals, Actavis Plc, Sanofi, Sun Pharmaceutical Industries Ltd, Mallinckrodt Pharmaceuticals, Endo Pharmaceuticals Inc, Egalet, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Meperidine (Demerol), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Meperidine (Demerol).
The Meperidine (Demerol) market size, estimations, and forecasts are provided in terms of sales volume (g) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Meperidine (Demerol) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Meperidine (Demerol) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Meperidine (Demerol) Market Report

Report Metric Details
Report Name Meperidine (Demerol) Market
Segment by Type
  • Powder
  • Liquid
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer Inc, Purdue Pharma, Boehringer Ingelheim, Janssen Pharmaceuticals, Actavis Plc, Sanofi, Sun Pharmaceutical Industries Ltd, Mallinckrodt Pharmaceuticals, Endo Pharmaceuticals Inc, Egalet
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Meperidine (Demerol) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Meperidine (Demerol) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Meperidine (Demerol) Market report?

Ans: The main players in the Meperidine (Demerol) Market are Pfizer Inc, Purdue Pharma, Boehringer Ingelheim, Janssen Pharmaceuticals, Actavis Plc, Sanofi, Sun Pharmaceutical Industries Ltd, Mallinckrodt Pharmaceuticals, Endo Pharmaceuticals Inc, Egalet

What are the Application segmentation covered in the Meperidine (Demerol) Market report?

Ans: The Applications covered in the Meperidine (Demerol) Market report are Anesthesia, Cough Suppressant, Diarrhea suppressant

What are the Type segmentation covered in the Meperidine (Demerol) Market report?

Ans: The Types covered in the Meperidine (Demerol) Market report are Powder, Liquid

Recommended Reports

Pain Management

Opioids & Dependence

Anesthetics & APIs

1 Meperidine (Demerol) Market Overview
1.1 Product Definition
1.2 Meperidine (Demerol) by Type
1.2.1 Global Meperidine (Demerol) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Powder
1.2.3 Liquid
1.3 Meperidine (Demerol) by Application
1.3.1 Global Meperidine (Demerol) Market Value by Application (2024 VS 2031)
1.3.2 Anesthesia
1.3.3 Cough Suppressant
1.3.4 Diarrhea suppressant
1.4 Global Meperidine (Demerol) Market Size Estimates and Forecasts
1.4.1 Global Meperidine (Demerol) Revenue 2020-2031
1.4.2 Global Meperidine (Demerol) Sales 2020-2031
1.4.3 Global Meperidine (Demerol) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Meperidine (Demerol) Market Competition by Manufacturers
2.1 Global Meperidine (Demerol) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Meperidine (Demerol) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Meperidine (Demerol) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Meperidine (Demerol), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Meperidine (Demerol), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Meperidine (Demerol), Product Type & Application
2.7 Global Key Manufacturers of Meperidine (Demerol), Date of Enter into This Industry
2.8 Global Meperidine (Demerol) Market Competitive Situation and Trends
2.8.1 Global Meperidine (Demerol) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Meperidine (Demerol) Players Market Share by Revenue
2.8.3 Global Meperidine (Demerol) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Meperidine (Demerol) Market Scenario by Region
3.1 Global Meperidine (Demerol) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Meperidine (Demerol) Sales by Region: 2020-2031
3.2.1 Global Meperidine (Demerol) Sales by Region: 2020-2025
3.2.2 Global Meperidine (Demerol) Sales by Region: 2026-2031
3.3 Global Meperidine (Demerol) Revenue by Region: 2020-2031
3.3.1 Global Meperidine (Demerol) Revenue by Region: 2020-2025
3.3.2 Global Meperidine (Demerol) Revenue by Region: 2026-2031
3.4 North America Meperidine (Demerol) Market Facts & Figures by Country
3.4.1 North America Meperidine (Demerol) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Meperidine (Demerol) Sales by Country (2020-2031)
3.4.3 North America Meperidine (Demerol) Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Meperidine (Demerol) Market Facts & Figures by Country
3.5.1 Europe Meperidine (Demerol) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Meperidine (Demerol) Sales by Country (2020-2031)
3.5.3 Europe Meperidine (Demerol) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Meperidine (Demerol) Market Facts & Figures by Region
3.6.1 Asia Pacific Meperidine (Demerol) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Meperidine (Demerol) Sales by Region (2020-2031)
3.6.3 Asia Pacific Meperidine (Demerol) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Meperidine (Demerol) Market Facts & Figures by Country
3.7.1 Latin America Meperidine (Demerol) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Meperidine (Demerol) Sales by Country (2020-2031)
3.7.3 Latin America Meperidine (Demerol) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Meperidine (Demerol) Market Facts & Figures by Country
3.8.1 Middle East and Africa Meperidine (Demerol) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Meperidine (Demerol) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Meperidine (Demerol) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Meperidine (Demerol) Sales by Type (2020-2031)
4.1.1 Global Meperidine (Demerol) Sales by Type (2020-2025)
4.1.2 Global Meperidine (Demerol) Sales by Type (2026-2031)
4.1.3 Global Meperidine (Demerol) Sales Market Share by Type (2020-2031)
4.2 Global Meperidine (Demerol) Revenue by Type (2020-2031)
4.2.1 Global Meperidine (Demerol) Revenue by Type (2020-2025)
4.2.2 Global Meperidine (Demerol) Revenue by Type (2026-2031)
4.2.3 Global Meperidine (Demerol) Revenue Market Share by Type (2020-2031)
4.3 Global Meperidine (Demerol) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Meperidine (Demerol) Sales by Application (2020-2031)
5.1.1 Global Meperidine (Demerol) Sales by Application (2020-2025)
5.1.2 Global Meperidine (Demerol) Sales by Application (2026-2031)
5.1.3 Global Meperidine (Demerol) Sales Market Share by Application (2020-2031)
5.2 Global Meperidine (Demerol) Revenue by Application (2020-2031)
5.2.1 Global Meperidine (Demerol) Revenue by Application (2020-2025)
5.2.2 Global Meperidine (Demerol) Revenue by Application (2026-2031)
5.2.3 Global Meperidine (Demerol) Revenue Market Share by Application (2020-2031)
5.3 Global Meperidine (Demerol) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer Inc
6.1.1 Pfizer Inc Company Information
6.1.2 Pfizer Inc Description and Business Overview
6.1.3 Pfizer Inc Meperidine (Demerol) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Inc Meperidine (Demerol) Product Portfolio
6.1.5 Pfizer Inc Recent Developments/Updates
6.2 Purdue Pharma
6.2.1 Purdue Pharma Company Information
6.2.2 Purdue Pharma Description and Business Overview
6.2.3 Purdue Pharma Meperidine (Demerol) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Purdue Pharma Meperidine (Demerol) Product Portfolio
6.2.5 Purdue Pharma Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Company Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Meperidine (Demerol) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Boehringer Ingelheim Meperidine (Demerol) Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Janssen Pharmaceuticals
6.4.1 Janssen Pharmaceuticals Company Information
6.4.2 Janssen Pharmaceuticals Description and Business Overview
6.4.3 Janssen Pharmaceuticals Meperidine (Demerol) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Janssen Pharmaceuticals Meperidine (Demerol) Product Portfolio
6.4.5 Janssen Pharmaceuticals Recent Developments/Updates
6.5 Actavis Plc
6.5.1 Actavis Plc Company Information
6.5.2 Actavis Plc Description and Business Overview
6.5.3 Actavis Plc Meperidine (Demerol) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Actavis Plc Meperidine (Demerol) Product Portfolio
6.5.5 Actavis Plc Recent Developments/Updates
6.6 Sanofi
6.6.1 Sanofi Company Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Meperidine (Demerol) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sanofi Meperidine (Demerol) Product Portfolio
6.6.5 Sanofi Recent Developments/Updates
6.7 Sun Pharmaceutical Industries Ltd
6.7.1 Sun Pharmaceutical Industries Ltd Company Information
6.7.2 Sun Pharmaceutical Industries Ltd Description and Business Overview
6.7.3 Sun Pharmaceutical Industries Ltd Meperidine (Demerol) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Sun Pharmaceutical Industries Ltd Meperidine (Demerol) Product Portfolio
6.7.5 Sun Pharmaceutical Industries Ltd Recent Developments/Updates
6.8 Mallinckrodt Pharmaceuticals
6.8.1 Mallinckrodt Pharmaceuticals Company Information
6.8.2 Mallinckrodt Pharmaceuticals Description and Business Overview
6.8.3 Mallinckrodt Pharmaceuticals Meperidine (Demerol) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Mallinckrodt Pharmaceuticals Meperidine (Demerol) Product Portfolio
6.8.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
6.9 Endo Pharmaceuticals Inc
6.9.1 Endo Pharmaceuticals Inc Company Information
6.9.2 Endo Pharmaceuticals Inc Description and Business Overview
6.9.3 Endo Pharmaceuticals Inc Meperidine (Demerol) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Endo Pharmaceuticals Inc Meperidine (Demerol) Product Portfolio
6.9.5 Endo Pharmaceuticals Inc Recent Developments/Updates
6.10 Egalet
6.10.1 Egalet Company Information
6.10.2 Egalet Description and Business Overview
6.10.3 Egalet Meperidine (Demerol) Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Egalet Meperidine (Demerol) Product Portfolio
6.10.5 Egalet Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Meperidine (Demerol) Industry Chain Analysis
7.2 Meperidine (Demerol) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Meperidine (Demerol) Production Mode & Process Analysis
7.4 Meperidine (Demerol) Sales and Marketing
7.4.1 Meperidine (Demerol) Sales Channels
7.4.2 Meperidine (Demerol) Distributors
7.5 Meperidine (Demerol) Customer Analysis
8 Meperidine (Demerol) Market Dynamics
8.1 Meperidine (Demerol) Industry Trends
8.2 Meperidine (Demerol) Market Drivers
8.3 Meperidine (Demerol) Market Challenges
8.4 Meperidine (Demerol) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Meperidine (Demerol) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Meperidine (Demerol) Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Meperidine (Demerol) Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Meperidine (Demerol) Sales (g) of Key Manufacturers (2020-2025)
 Table 5. Global Meperidine (Demerol) Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Meperidine (Demerol) Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Meperidine (Demerol) Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Meperidine (Demerol) Average Price (USD/mg) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Meperidine (Demerol), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Meperidine (Demerol), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Meperidine (Demerol), Product Type & Application
 Table 12. Global Key Manufacturers of Meperidine (Demerol), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Meperidine (Demerol) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meperidine (Demerol) as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Meperidine (Demerol) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Meperidine (Demerol) Sales by Region (2020-2025) & (g)
 Table 18. Global Meperidine (Demerol) Sales Market Share by Region (2020-2025)
 Table 19. Global Meperidine (Demerol) Sales by Region (2026-2031) & (g)
 Table 20. Global Meperidine (Demerol) Sales Market Share by Region (2026-2031)
 Table 21. Global Meperidine (Demerol) Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Meperidine (Demerol) Revenue Market Share by Region (2020-2025)
 Table 23. Global Meperidine (Demerol) Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Meperidine (Demerol) Revenue Market Share by Region (2026-2031)
 Table 25. North America Meperidine (Demerol) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Meperidine (Demerol) Sales by Country (2020-2025) & (g)
 Table 27. North America Meperidine (Demerol) Sales by Country (2026-2031) & (g)
 Table 28. North America Meperidine (Demerol) Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Meperidine (Demerol) Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Meperidine (Demerol) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Meperidine (Demerol) Sales by Country (2020-2025) & (g)
 Table 32. Europe Meperidine (Demerol) Sales by Country (2026-2031) & (g)
 Table 33. Europe Meperidine (Demerol) Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Meperidine (Demerol) Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Meperidine (Demerol) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Meperidine (Demerol) Sales by Region (2020-2025) & (g)
 Table 37. Asia Pacific Meperidine (Demerol) Sales by Region (2026-2031) & (g)
 Table 38. Asia Pacific Meperidine (Demerol) Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Meperidine (Demerol) Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Meperidine (Demerol) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Meperidine (Demerol) Sales by Country (2020-2025) & (g)
 Table 42. Latin America Meperidine (Demerol) Sales by Country (2026-2031) & (g)
 Table 43. Latin America Meperidine (Demerol) Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Meperidine (Demerol) Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Meperidine (Demerol) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Meperidine (Demerol) Sales by Country (2020-2025) & (g)
 Table 47. Middle East and Africa Meperidine (Demerol) Sales by Country (2026-2031) & (g)
 Table 48. Middle East and Africa Meperidine (Demerol) Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Meperidine (Demerol) Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Meperidine (Demerol) Sales (g) by Type (2020-2025)
 Table 51. Global Meperidine (Demerol) Sales (g) by Type (2026-2031)
 Table 52. Global Meperidine (Demerol) Sales Market Share by Type (2020-2025)
 Table 53. Global Meperidine (Demerol) Sales Market Share by Type (2026-2031)
 Table 54. Global Meperidine (Demerol) Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Meperidine (Demerol) Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Meperidine (Demerol) Revenue Market Share by Type (2020-2025)
 Table 57. Global Meperidine (Demerol) Revenue Market Share by Type (2026-2031)
 Table 58. Global Meperidine (Demerol) Price (USD/mg) by Type (2020-2025)
 Table 59. Global Meperidine (Demerol) Price (USD/mg) by Type (2026-2031)
 Table 60. Global Meperidine (Demerol) Sales (g) by Application (2020-2025)
 Table 61. Global Meperidine (Demerol) Sales (g) by Application (2026-2031)
 Table 62. Global Meperidine (Demerol) Sales Market Share by Application (2020-2025)
 Table 63. Global Meperidine (Demerol) Sales Market Share by Application (2026-2031)
 Table 64. Global Meperidine (Demerol) Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Meperidine (Demerol) Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Meperidine (Demerol) Revenue Market Share by Application (2020-2025)
 Table 67. Global Meperidine (Demerol) Revenue Market Share by Application (2026-2031)
 Table 68. Global Meperidine (Demerol) Price (USD/mg) by Application (2020-2025)
 Table 69. Global Meperidine (Demerol) Price (USD/mg) by Application (2026-2031)
 Table 70. Pfizer Inc Company Information
 Table 71. Pfizer Inc Description and Business Overview
 Table 72. Pfizer Inc Meperidine (Demerol) Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
 Table 73. Pfizer Inc Meperidine (Demerol) Product
 Table 74. Pfizer Inc Recent Developments/Updates
 Table 75. Purdue Pharma Company Information
 Table 76. Purdue Pharma Description and Business Overview
 Table 77. Purdue Pharma Meperidine (Demerol) Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
 Table 78. Purdue Pharma Meperidine (Demerol) Product
 Table 79. Purdue Pharma Recent Developments/Updates
 Table 80. Boehringer Ingelheim Company Information
 Table 81. Boehringer Ingelheim Description and Business Overview
 Table 82. Boehringer Ingelheim Meperidine (Demerol) Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
 Table 83. Boehringer Ingelheim Meperidine (Demerol) Product
 Table 84. Boehringer Ingelheim Recent Developments/Updates
 Table 85. Janssen Pharmaceuticals Company Information
 Table 86. Janssen Pharmaceuticals Description and Business Overview
 Table 87. Janssen Pharmaceuticals Meperidine (Demerol) Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
 Table 88. Janssen Pharmaceuticals Meperidine (Demerol) Product
 Table 89. Janssen Pharmaceuticals Recent Developments/Updates
 Table 90. Actavis Plc Company Information
 Table 91. Actavis Plc Description and Business Overview
 Table 92. Actavis Plc Meperidine (Demerol) Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
 Table 93. Actavis Plc Meperidine (Demerol) Product
 Table 94. Actavis Plc Recent Developments/Updates
 Table 95. Sanofi Company Information
 Table 96. Sanofi Description and Business Overview
 Table 97. Sanofi Meperidine (Demerol) Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
 Table 98. Sanofi Meperidine (Demerol) Product
 Table 99. Sanofi Recent Developments/Updates
 Table 100. Sun Pharmaceutical Industries Ltd Company Information
 Table 101. Sun Pharmaceutical Industries Ltd Description and Business Overview
 Table 102. Sun Pharmaceutical Industries Ltd Meperidine (Demerol) Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
 Table 103. Sun Pharmaceutical Industries Ltd Meperidine (Demerol) Product
 Table 104. Sun Pharmaceutical Industries Ltd Recent Developments/Updates
 Table 105. Mallinckrodt Pharmaceuticals Company Information
 Table 106. Mallinckrodt Pharmaceuticals Description and Business Overview
 Table 107. Mallinckrodt Pharmaceuticals Meperidine (Demerol) Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
 Table 108. Mallinckrodt Pharmaceuticals Meperidine (Demerol) Product
 Table 109. Mallinckrodt Pharmaceuticals Recent Developments/Updates
 Table 110. Endo Pharmaceuticals Inc Company Information
 Table 111. Endo Pharmaceuticals Inc Description and Business Overview
 Table 112. Endo Pharmaceuticals Inc Meperidine (Demerol) Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
 Table 113. Endo Pharmaceuticals Inc Meperidine (Demerol) Product
 Table 114. Endo Pharmaceuticals Inc Recent Developments/Updates
 Table 115. Egalet Company Information
 Table 116. Egalet Description and Business Overview
 Table 117. Egalet Meperidine (Demerol) Sales (g), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
 Table 118. Egalet Meperidine (Demerol) Product
 Table 119. Egalet Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Meperidine (Demerol) Distributors List
 Table 123. Meperidine (Demerol) Customers List
 Table 124. Meperidine (Demerol) Market Trends
 Table 125. Meperidine (Demerol) Market Drivers
 Table 126. Meperidine (Demerol) Market Challenges
 Table 127. Meperidine (Demerol) Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Meperidine (Demerol)
 Figure 2. Global Meperidine (Demerol) Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Meperidine (Demerol) Market Share by Type: 2024 & 2031
 Figure 4. Powder Product Picture
 Figure 5. Liquid Product Picture
 Figure 6. Global Meperidine (Demerol) Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Meperidine (Demerol) Market Share by Application: 2024 & 2031
 Figure 8. Anesthesia
 Figure 9. Cough Suppressant
 Figure 10. Diarrhea suppressant
 Figure 11. Global Meperidine (Demerol) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Meperidine (Demerol) Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Meperidine (Demerol) Sales (2020-2031) & (g)
 Figure 14. Global Meperidine (Demerol) Average Price (USD/mg) & (2020-2031)
 Figure 15. Meperidine (Demerol) Report Years Considered
 Figure 16. Meperidine (Demerol) Sales Share by Manufacturers in 2024
 Figure 17. Global Meperidine (Demerol) Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Meperidine (Demerol) Players: Market Share by Revenue in Meperidine (Demerol) in 2024
 Figure 19. Meperidine (Demerol) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Meperidine (Demerol) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Meperidine (Demerol) Sales Market Share by Country (2020-2031)
 Figure 22. North America Meperidine (Demerol) Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Meperidine (Demerol) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Meperidine (Demerol) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Meperidine (Demerol) Sales Market Share by Country (2020-2031)
 Figure 26. Europe Meperidine (Demerol) Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Meperidine (Demerol) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Meperidine (Demerol) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Meperidine (Demerol) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Meperidine (Demerol) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Meperidine (Demerol) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Meperidine (Demerol) Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Meperidine (Demerol) Revenue Market Share by Region (2020-2031)
 Figure 34. China Meperidine (Demerol) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Meperidine (Demerol) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Meperidine (Demerol) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Meperidine (Demerol) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Meperidine (Demerol) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Meperidine (Demerol) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Meperidine (Demerol) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Meperidine (Demerol) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Meperidine (Demerol) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Meperidine (Demerol) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Meperidine (Demerol) Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Meperidine (Demerol) Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Meperidine (Demerol) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Meperidine (Demerol) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Meperidine (Demerol) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Meperidine (Demerol) Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Meperidine (Demerol) Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Meperidine (Demerol) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Meperidine (Demerol) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. U.A.E Meperidine (Demerol) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Meperidine (Demerol) by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Meperidine (Demerol) by Type (2020-2031)
 Figure 56. Global Meperidine (Demerol) Price (USD/mg) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Meperidine (Demerol) by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Meperidine (Demerol) by Application (2020-2031)
 Figure 59. Global Meperidine (Demerol) Price (USD/mg) by Application (2020-2031)
 Figure 60. Meperidine (Demerol) Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart